healthy individuals
Conditions
Interventions
Ingestion of test food for 8 weeks
Ingestion of placebo food for 8 weeks
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Subjects of men and women aged 20 to 64 (2) Subject feeling tired (3) Subjects who are vulnerable to colds and influenza as a consciousness (4) Subjects who do not perform high-intensity exercise on a daily basis (5) Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.
Exclusion criteria
Exclusion criteria: (1) Subjects with heart, liver, and kidney diseases (including complications of other diseases) (2) Subjects with a history of cardiovascular disease (3) Subjects with diabetes (4) Subjects with diseases currently being treated (5) Subjects with abnormal cardiac function (6) Subjects with autoimmune disease (7) Subjects taking warfarin (8) Subjects using immunosuppressive agents such as steroids (9) Subjects who are allergic to food and drugs (10) Subjects with anemia symptoms (11) Female subjects wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating female subjects (12) Those who play intense sports and subjects who are on a diet (13) Subjects with extremely irregular eating habits (14) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (15) Subjects who drink more than 60 g of average daily pure alcohol (16) Subjects who smoke an average of 21 or more cigarettes a day (17) Subjects with irregular lives such as shift workers (18) Subjects who are participating in or will participate in other clinical trials at the start of this study. (19) Other subjects judged by the investigator or the investigator to be inappropriate for the examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immunity evaluation, Incidence and severity of the common cold (upper respiratory tract infections, influenza, tiredness) Blood /saliva hormones Subjective indicators of health-related quality of life | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness Support Co., Ltd. Clinical Trial Division
Outcome results
None listed